DEFB118
gene geneOn this page
Also known as dJ1018D12.3DEFB-18ESC42
Summary
DEFB118 (defensin beta 118, HGNC:16196) is a protein-coding gene on chromosome 20q11.21, encoding Defensin beta 118 (Q96PH6). Host defense peptide that exhibits antimicrobial activity against both Gram-negative bacteria, such as E.coli and S.typhimurium, and Gram-positive bacteria, such as S.aureus and B.subtilis.
This gene encodes a member of the beta subfamily of defensins. Beta-defensins are antimicrobial peptides that protect tissues and organs from infection by a variety of microorganisms. Expression of this gene is regulated by androgen, and the encoded protein binds to sperm and exhibits antibacterial activity against E. coli. This gene is found in a cluster with other beta-defensin genes on the long arm of chromosome 20.
Source: NCBI Gene 117285 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_054112
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16196 |
| Approved symbol | DEFB118 |
| Name | defensin beta 118 |
| Location | 20q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ1018D12.3, DEFB-18, ESC42 |
| Ensembl gene | ENSG00000131068 |
| Ensembl biotype | protein_coding |
| OMIM | 607650 |
| Entrez | 117285 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000253381
RefSeq mRNA: 1 — MANE Select: NM_054112
NM_054112
CCDS: CCDS13177
Canonical transcript exons
ENST00000253381 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000898434 | 31368601 | 31368708 |
| ENSE00001301255 | 31372857 | 31373923 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 99.29.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4443 / max 782.1952, expressed in 9 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183958 | 0.4443 | 9 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 99.29 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 84.12 | gold quality |
| cardia of stomach | UBERON:0001162 | 83.98 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.21 | gold quality |
| vena cava | UBERON:0004087 | 83.20 | gold quality |
| epididymis | UBERON:0001301 | 82.63 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 81.91 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 81.50 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 80.80 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 80.61 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 80.30 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 79.15 | gold quality |
| ventral tegmental area | UBERON:0002691 | 79.00 | gold quality |
| body of tongue | UBERON:0011876 | 78.74 | gold quality |
| tongue | UBERON:0001723 | 78.41 | gold quality |
| superior surface of tongue | UBERON:0007371 | 78.41 | gold quality |
| cerebellar vermis | UBERON:0004720 | 78.37 | gold quality |
| thymus | UBERON:0002370 | 78.06 | gold quality |
| medulla oblongata | UBERON:0001896 | 78.03 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 78.00 | gold quality |
| pericardium | UBERON:0002407 | 77.81 | gold quality |
| trachea | UBERON:0003126 | 77.61 | gold quality |
| pons | UBERON:0000988 | 77.58 | gold quality |
| pylorus | UBERON:0001166 | 77.49 | gold quality |
| saphenous vein | UBERON:0007318 | 77.33 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.20 | gold quality |
| superficial temporal artery | UBERON:0001614 | 76.73 | gold quality |
| nipple | UBERON:0002030 | 76.62 | gold quality |
| renal medulla | UBERON:0000362 | 76.54 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 76.51 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.13 |
| E-HCAD-38 | no | 3024.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting DEFB118, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-370-5P | 99.78 | 66.81 | 706 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-122B-5P | 99.46 | 70.81 | 1457 |
| HSA-MIR-208A-5P | 99.42 | 70.83 | 1913 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
| HSA-MIR-3606-5P | 99.31 | 69.67 | 1168 |
| HSA-MIR-7702 | 99.06 | 65.95 | 698 |
| HSA-MIR-8066 | 99.05 | 68.66 | 1532 |
Literature-anchored findings (GeneRIF, showing 2)
- DEFB118 may contribute to epididymal innate immunity and provide antimicrobial activity against microorganisms attacking sperm in the male and female reproductive tracts. (PMID:15033915)
- The truncated human beta-defensin 118 can modulate lipopolysaccharide mediated inflammatory response in RAW264.7 macrophages. (PMID:33181266)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb21 | ENSMUSG00000056544 |
| rattus_norvegicus | Defb21 | ENSRNOG00000023154 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Defensin beta 118 — Q96PH6 (reviewed: Q96PH6)
Alternative names: Beta-defensin 18, Epididymal secretory protein 13.6
All UniProt accessions (2): Q96PH6, A0A384MTK2
UniProt curated annotations — full annotation on UniProt →
Function. Host defense peptide that exhibits antimicrobial activity against both Gram-negative bacteria, such as E.coli and S.typhimurium, and Gram-positive bacteria, such as S.aureus and B.subtilis. Inhibits cell adhesion of E.coli on intestinal epithelial enterocytes. Causes rapid permeabilization of both the outer and inner membrane of E.coli, leading to morphological alterations on the bacterial surface. Binds to bacterial lipopolysaccharides (LPS) with high affinity, and may thereby be involved in immunoregulation through LPS neutralization. May contribute to epididymal innate immunity and protect the sperm against attack by microorganisms.
Subcellular location. Secreted.
Tissue specificity. High-level and epididymis-specific expression. Most abundant in the epithelium of the caput and present in the epididymis lumen and bound to sperm. Also expressed in pancreas.
Post-translational modifications. The three-dimensional structure formed by the three intramolecular disulfide bridges is indispensable for antimicrobial activity.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_473453* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
| IPR050544 | Beta-defensin | Family |
Pfam: PF13841
UniProt features (10 total): disulfide bond 3, compositionally biased region 2, signal peptide 1, peptide 1, propeptide 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96PH6-F1 | 63.26 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 27–54, 34–48, 38–55
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 60 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_MALE_GAMETE_GENERATION, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY, GOBP_HUMORAL_IMMUNE_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, GOBP_RESPONSE_TO_LIPID, GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM, GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY
GO Biological Process (11): cell-matrix adhesion (GO:0007160), negative regulation of cell adhesion (GO:0007162), spermatogenesis (GO:0007283), killing of cells of another organism (GO:0031640), negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665), defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response to Gram-negative bacterium (GO:0050829), defense response to Gram-positive bacterium (GO:0050830), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), defense response (GO:0006952)
GO Molecular Function (3): lipopolysaccharide binding (GO:0001530), membrane destabilizing activity (GO:0140912), protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response to bacterium | 2 |
| cell-substrate adhesion | 1 |
| cell adhesion | 1 |
| regulation of cell adhesion | 1 |
| negative regulation of cellular process | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cell killing | 1 |
| disruption of cell in another organism | 1 |
| negative regulation of response to biotic stimulus | 1 |
| negative regulation of signal transduction | 1 |
| lipopolysaccharide-mediated signaling pathway | 1 |
| regulation of lipopolysaccharide-mediated signaling pathway | 1 |
| negative regulation of response to external stimulus | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| antimicrobial humoral response | 1 |
| response to stress | 1 |
| lipid binding | 1 |
| carbohydrate derivative binding | 1 |
| molecular_function | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
348 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB118 | DEFB126 | Q9BYW3 | 749 |
| DEFB118 | DEFB129 | Q9H1M3 | 726 |
| DEFB118 | DEFB114 | Q30KQ6 | 710 |
| DEFB118 | DEFB127 | Q9H1M4 | 665 |
| DEFB118 | DEFB116 | Q30KQ4 | 652 |
| DEFB118 | DEFB115 | Q30KQ5 | 611 |
| DEFB118 | DEFB132 | Q7Z7B7 | 607 |
| DEFB118 | DEFB1 | P60022 | 580 |
| DEFB118 | DEFB131A | P59861 | 576 |
| DEFB118 | A0A0G2JN59 | A0A0G2JN59 | 518 |
| DEFB118 | DEFB108B | Q8NET1 | 506 |
| DEFB118 | EGF | P01133 | 492 |
| DEFB118 | WFDC9 | Q8NEX5 | 480 |
| DEFB118 | DEFB104A | Q8WTQ1 | 475 |
| DEFB118 | DEFB105A | Q8NG35 | 470 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GUCA1A | DEFB118 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB118 | IFI30 | psi-mi:“MI:0914”(association) | 0.350 |
| GUCA1A | DEFB118 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): DEFB118 (Two-hybrid), THOP1 (Affinity Capture-MS), IFI30 (Affinity Capture-MS)
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H225, A4H227, A4H228, A4H238, A4H240, A4H253, A4H254, A4H255, A4H257, A4H258, A4H259, A4H262, A4H263, A4H264, A4H265, P0C8A8, P0DY26, P0DY27, Q29RT9, Q30KJ7, Q30KK0, Q30KK1, Q30KK9, Q30KL1, Q30KL7, Q30KP3, Q30KP5, Q30KQ4, Q30KQ5, Q30KQ8, Q30KR1, Q30KT5, Q32P86, Q32ZH2, Q32ZH6, Q3UW43
Diamond homologs: A4H220, A4H221, A4H222, A4H223, P0C8A5, Q30KK6, Q30KK9, Q30KQ5, Q5J5C9, Q95LI0, Q96PH6, P0C8A6, A4H225, A4H226, A4H227, A4H228, A4H235, A4H236, Q30KK5, Q30KP9, Q5J5D0, Q5J600, Q5J602, Q8K3I8, Q8N688, Q8N690
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
235 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:31369170:G:GG | donor_gain | 0.9800 |
| 20:31369178:C:G | donor_gain | 0.9800 |
| 20:31372855:A:AG | acceptor_gain | 0.9800 |
| 20:31372856:G:GG | acceptor_gain | 0.9800 |
| 20:31368707:AGGTA:A | donor_loss | 0.9700 |
| 20:31368708:G:GA | donor_loss | 0.9700 |
| 20:31368709:GTAAT:G | donor_loss | 0.9700 |
| 20:31368710:T:G | donor_loss | 0.9700 |
| 20:31372856:GC:G | acceptor_gain | 0.9700 |
| 20:31369169:A:AG | donor_gain | 0.9600 |
| 20:31369178:C:CG | donor_gain | 0.9600 |
| 20:31371306:G:T | donor_gain | 0.9600 |
| 20:31372856:GCCT:G | acceptor_gain | 0.9600 |
| 20:31370105:GG:G | donor_gain | 0.9400 |
| 20:31370106:GG:G | donor_gain | 0.9400 |
| 20:31372848:A:AG | acceptor_gain | 0.9300 |
| 20:31371306:G:GT | donor_gain | 0.9200 |
| 20:31368725:G:T | donor_gain | 0.9100 |
| 20:31369204:T:G | donor_gain | 0.9100 |
| 20:31372853:TCAGC:T | acceptor_gain | 0.9100 |
| 20:31372854:CAG:C | acceptor_gain | 0.9100 |
| 20:31369204:T:TG | donor_gain | 0.9000 |
| 20:31372852:TTCAG:T | acceptor_gain | 0.9000 |
| 20:31372853:TCA:T | acceptor_loss | 0.9000 |
| 20:31372855:AGC:A | acceptor_loss | 0.9000 |
| 20:31372855:A:T | acceptor_gain | 0.8900 |
| 20:31372856:GCCTA:G | acceptor_gain | 0.8900 |
| 20:31372856:G:C | acceptor_gain | 0.8700 |
| 20:31372856:GCC:G | acceptor_gain | 0.8500 |
| 20:31372849:T:G | acceptor_gain | 0.8400 |
AlphaMissense
800 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:31372910:T:A | C38S | 0.989 |
| 20:31372911:G:C | C38S | 0.989 |
| 20:31372961:T:A | C55S | 0.986 |
| 20:31372962:G:C | C55S | 0.986 |
| 20:31372877:T:A | C27S | 0.985 |
| 20:31372878:G:C | C27S | 0.985 |
| 20:31372898:T:A | C34S | 0.985 |
| 20:31372899:G:C | C34S | 0.985 |
| 20:31372958:T:A | C54S | 0.983 |
| 20:31372959:G:C | C54S | 0.983 |
| 20:31372940:T:A | C48S | 0.974 |
| 20:31372941:G:C | C48S | 0.974 |
| 20:31372893:G:A | G32E | 0.973 |
| 20:31372959:G:A | C54Y | 0.973 |
| 20:31372962:G:A | C55Y | 0.973 |
| 20:31372910:T:C | C38R | 0.972 |
| 20:31372958:T:C | C54R | 0.972 |
| 20:31372961:T:C | C55R | 0.972 |
| 20:31372941:G:A | C48Y | 0.971 |
| 20:31372960:C:G | C54W | 0.971 |
| 20:31372877:T:C | C27R | 0.969 |
| 20:31372963:C:G | C55W | 0.967 |
| 20:31372899:G:A | C34Y | 0.966 |
| 20:31372911:G:A | C38Y | 0.965 |
| 20:31372903:G:C | R35S | 0.963 |
| 20:31372903:G:T | R35S | 0.963 |
| 20:31372959:G:T | C54F | 0.962 |
| 20:31372942:C:G | C48W | 0.961 |
| 20:31372911:G:T | C38F | 0.960 |
| 20:31372962:G:T | C55F | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000512055 (20:31373794 T>A), RS1000828890 (20:31374094 A>G), RS1000946528 (20:31374073 C>T), RS1001019272 (20:31367793 A>G), RS1001154415 (20:31367575 C>A,T), RS1001159530 (20:31367599 G>A), RS1001438614 (20:31367756 G>C), RS1003023050 (20:31370781 C>T), RS1003361641 (20:31372105 G>A), RS1003369371 (20:31372123 G>T), RS1003977606 (20:31367271 T>C), RS1004332886 (20:31367025 G>C), RS1005048606 (20:31373683 G>A,T), RS1005159533 (20:31373302 T>C), RS1005444631 (20:31370053 A>C,G)
Disease associations
OMIM: gene MIM:607650 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004639_6 | Prudent dietary pattern | 2.000000e-06 |
| GCST010346_28 | TPE interval (resting) | 3.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004644 | TPE interval measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Folic Acid | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.